Heart Transplantation 1987–2007: 20 Years' Experience at Chulalongkorn Hospital

Ongcharit, Pat; Wongkietkachorn, Kuanjira; Sritangsirikul, Supaporn; Namchaisiri, Jule; Singhatanatkit, S.; Luengtaviboon, Kittichai; Benjacholamas, Vichai; Ongcharit, C

doi:10.1016/j.transproceed.2008.08.077

Cited by 3 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…First, survival even to 15–20 years post‐CTX is no longer uncommon: worldwide survival rates are 38% at 15 years and 22% at 20 years among heart recipients, and 20% and 12%, respectively, in lung recipients 1,2 . Experienced centers report still higher rates 10‐20 . The literature on long‐term survivors focuses almost exclusively on describing their health status and identifying clinical and psychosocial prognostic factors for morbidity and mortality, 3,13,16,20–27 rather than considering HRQOL and its predictors.…”

Section: Introductionmentioning

confidence: 99%

“…1,2 Experienced centers report still higher rates. [10][11][12][13][14][15][16][17][18][19][20] The literature on long-term survivors focuses almost exclusively on describing their health status and identifying clinical and psychosocial prognostic factors for morbidity and mortality, 3,13,16,[20][21][22][23][24][25][26][27] rather than considering HRQOL and its predictors.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Health‐related quality of life and psychological indicators of thriving 15–19 years after heart or lung transplantation

Dew

DiMartini

Posluszny

et al. 2022

Clinical Transplantation

View full text Add to dashboard Cite

Background: Survival into the second decade after cardiothoracic transplantation (CTX) is no longer uncommon. Few data exist on any health-related quality of life (HRQOL) impairments survivors face, or whether they may even experience positive psychological outcomes indicative of "thriving" (e.g., personal growth). We provide such data in a long-term survivor cohort. Methods: Among 304 patients prospectively studied across the first 2 years post-CTX, we re-interviewed patients ≥15 years post-CTX. We (a) examined levels of HRQOL and positive psychological outcomes (posttraumatic growth related to CTX, purpose in life, life satisfaction) at follow-up, (b) evaluated change since transplant with mixed-effects models, and (c) identified psychosocial and clinical correlates of study outcomes with multivariable regression. Results: Of 77 survivors, 64 (83%) were assessed (35 heart, 29 lung recipients; 15-19 years post-CTX). Physical HRQOL was poorer than the general population norm and earlier post-transplant levels (P's < .001). Mental HRQOL exceeded the norm (P < .001), with little temporal change (P = .070). Mean positive psychological outcome scores exceeded scales' midpoints at follow-up. Life satisfaction, assessed

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Health‐related quality of life and psychological indicators of thriving 15–19 years after heart or lung transplantation

Dew

DiMartini

Posluszny

et al. 2022

Clinical Transplantation

View full text Add to dashboard Cite

show abstract

“…Only few papers with patients surviving more than 20 years after OHT have been reported (2,3,(5)(6)(7)(8). There are only small cohorts, and therefore the clinical characteristics associated with prolonged survival are not very well understood.…”

Section: Introductionmentioning

confidence: 99%

Resumé of the challenges and burden of living with transplanted hearts for >31 years

Delmo¹,

Javier²,

Wagner³

et al. 2021

Cardiovasc Diagn Ther

View full text Add to dashboard Cite

This has improved, albeit slight, as compared to the median survival of 10 years (n=78,050) with 122 patients at risk in 22 years, based on the 1982-2007 registry of the ISHLT. The development of new immunosuppressive drugs which allow a variety of immunosuppressive regimens, tailored to the individual patient, has contributed to this improvement, since rejection and the adverse sequelae of immunosuppression has been better controlled. After

show abstract